{"id":2637,"date":"2019-10-23T15:25:05","date_gmt":"2019-10-23T19:25:05","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/the-delaware-times-reports-on-260m-historic-opioid-deal\/"},"modified":"2022-06-27T02:34:08","modified_gmt":"2022-06-27T06:34:08","slug":"the-delaware-times-informs-on-260m-historic-opioid-deal","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/es\/libros-blancos\/the-delaware-times-informs-on-260m-historic-opioid-deal\/","title":{"rendered":"The Delaware Times informa sobre el acuerdo hist\u00f3rico de opioides $260M"},"content":{"rendered":"<p>Los distribuidores de medicamentos AmerisourceBergen, Cardnial Health y McKesson pagar\u00e1n $215 millones combinados, dijo Hunter Shkolnik, abogado del condado de Cuyahoga. El fabricante de medicamentos con sede en Israel, Teva, contribuir\u00e1 con $20 millones en efectivo y $25 millones en Suboxone gen\u00e9rico, un medicamento que se usa para tratar la adicci\u00f3n a los opioides.<\/p>","protected":false},"excerpt":{"rendered":"<p>Los distribuidores de medicamentos AmerisourceBergen, Cardnial Health y McKesson pagar\u00e1n $215 millones combinados, dijo Hunter Shkolnik, abogado del condado de Cuyahoga. El fabricante de medicamentos con sede en Israel, Teva, contribuir\u00e1 con $20 millones en efectivo...<\/p>","protected":false},"featured_media":0,"menu_order":246,"template":"","whitepaper_category":[75,98,253,254],"whitepaper-source":[281],"class_list":["post-2637","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-associated-press"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepapers\/2637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepapers\/2637\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/media?parent=2637"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepaper_category?post=2637"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/es\/wp-json\/wp\/v2\/whitepaper-source?post=2637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}